Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

20042,578 citationsReview

Authors

Good health and well-being

Published in: Nature Reviews Drug Discovery

Volume 3, Issue 5, pp. 391-400

Field-Weighted Citation Impact: 40.63